HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -38.7% | 9,287 | -6.6% | 0.00% | – |
| Q4 2021 | $75,000 | -7.4% | 9,940 | -2.9% | 0.00% | – |
| Q3 2021 | $81,000 | -44.1% | 10,238 | -2.3% | 0.00% | – |
| Q2 2021 | $145,000 | -12.1% | 10,481 | +32.7% | 0.00% | -100.0% |
| Q1 2021 | $165,000 | +58.7% | 7,896 | +26.5% | 0.00% | – |
| Q4 2020 | $104,000 | -2.8% | 6,241 | -1.3% | 0.00% | -100.0% |
| Q3 2020 | $107,000 | 0.0% | 6,323 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | +114.0% | 6,467 | +49.0% | 0.00% | – |
| Q1 2020 | $50,000 | -26.5% | 4,341 | -5.5% | 0.00% | – |
| Q4 2019 | $68,000 | +7.9% | 4,593 | +0.3% | 0.00% | – |
| Q3 2019 | $63,000 | +28.6% | 4,580 | +21.5% | 0.00% | – |
| Q2 2019 | $49,000 | +226.7% | 3,771 | +130.5% | 0.00% | – |
| Q1 2019 | $15,000 | – | 1,636 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |